Telemedicine Education for Caregivers and Asthma Control in Children
Launched by CAN THO UNIVERSITY OF MEDICINE AND PHARMACY · Dec 22, 2024
Trial Information
Current as of November 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how telemedicine-based education can help caregivers improve asthma control in children who are struggling with uncontrolled asthma. The goal is to provide caregivers with the knowledge and resources they need to manage their child's condition more effectively. By using remote consultations and guidance, the study aims to help caregivers feel more confident in their ability to support their child's asthma management, which can lead to better health outcomes for the children involved.
To be eligible for the trial, children aged between 4 and 18 years old who have been diagnosed with uncontrolled asthma according to specific guidelines can participate, as long as they have been receiving care at a pediatric asthma unit for at least one month. However, the study cannot include children who have siblings in the trial or those who are currently involved in another clinical study. Participants can expect to receive education and support through telemedicine sessions, which are designed to help them understand and manage asthma better. This trial is actively recruiting participants who meet these criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department.
- Exclusion Criteria:
- • Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire.
- • Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors.
- • Pediatric patients who have siblings participating in the study.
- • Patients currently participating in another clinical study (excluding non-interventional studies or registries).
- • Failure to return for a second visit within 6 months following enrollment.
About Can Tho University Of Medicine And Pharmacy
Can Tho University of Medicine and Pharmacy is a prestigious academic institution located in Vietnam, dedicated to advancing healthcare education, research, and clinical practice. As a clinical trial sponsor, the university focuses on innovative research initiatives aimed at improving medical knowledge and patient outcomes. With a commitment to ethical standards and rigorous scientific methodology, the institution collaborates with healthcare professionals and industry partners to conduct studies that address pressing health issues in the region. Through its comprehensive approach to clinical research, Can Tho University of Medicine and Pharmacy aims to contribute significantly to the global medical community and enhance the quality of healthcare delivery in Vietnam and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Can Tho City, Vietnam
Cần Thơ, Vietnam
Patients applied
Trial Officials
Nghia Quang Bui, MD, PhD
Study Chair
Can Tho University of Medicine and Pharmacy
Ly Cong Tran, MD, MSc
Study Director
Can Tho University of Medicine and Pharmacy
Thang Hoang Le, MD
Principal Investigator
Can Tho University of Medicine and Pharmacy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported